GE HealthCare CTO granted 23,339 PSUs in stock

GE HealthCare Technologies Inc.’s Chief Technology Officer, Kass-Hout Taha, reported equity transactions in company common stock.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc.’s Chief Technology Officer, Kass-Hout Taha, reported equity transactions in company common stock. On February 12, 2026, he acquired 23,339 shares at $0 per share through the vesting of performance stock units granted on March 1, 2023, after performance criteria were certified as met. On the same date, 7,787 shares were disposed of at $79.20 per share to cover tax withholding obligations related to this vesting. Following these transactions, he directly owned 79,655 shares of GE HealthCare common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Kass-Hout Taha

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	23,339	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	7,787	$79.20	$617K

Holdings After Transaction: Common Stock, par value $0.01 per share — 79,655 shares (Direct)

Footnotes (2)

1. F1. Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026.
2. F2. Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did GEHC’s Chief Technology Officer report?

GE HealthCare’s Chief Technology Officer, Kass-Hout Taha, reported vesting of 23,339 performance-based shares and a related tax-share withholding of 7,787 shares on February 12, 2026. These transactions reflect equity compensation settlement rather than open-market buying or selling.

How many GEHC shares did the CTO acquire through performance stock units?

Kass-Hout Taha acquired 23,339 GE HealthCare common shares when performance stock units vested on February 12, 2026. These PSUs were originally granted March 1, 2023 and vested after performance criteria were satisfied and certified by the company’s Talent, Culture, and Compensation Committee.

Why were 7,787 GEHC shares disposed of by the CTO?

The 7,787 GE HealthCare shares were withheld to satisfy tax withholding obligations tied to the vesting of performance stock units. This tax-withholding disposition, coded “F” on the form, is a common administrative step rather than a discretionary open-market sale by the insider.

What is Kass-Hout Taha’s GEHC shareholding after these transactions?

After the reported February 12, 2026 transactions, Kass-Hout Taha directly owned 79,655 shares of GE HealthCare common stock. This figure reflects the net result of 23,339 shares from vested performance stock units and 7,787 shares withheld for associated tax obligations.

What were the terms of the GEHC performance stock units that vested?

The performance stock units were granted on March 1, 2023, each representing one share of GE HealthCare common stock. They vested on February 12, 2026 after performance criteria were satisfied and certified by the Talent, Culture, and Compensation Committee, resulting in delivery of 23,339 shares.

Did the GEHC CTO buy or sell shares on the open market?

The filing shows no open-market purchases or sales by the GE HealthCare CTO. Shares were acquired through vesting of previously granted performance stock units and some were disposed of solely to cover tax withholding obligations associated with that vesting event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 07:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kass-Hout Taha

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/12/2026		A		23,339(1)	A	$0	87,442	D
Common Stock, par value $0.01 per share	02/12/2026		F		7,787(2)	D	$79.2	79,655	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026.

2. Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.